SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US Listed > Biotechs >

Repros Therapeutics, Inc. (RPRX)

RPRX RSS Feed
Add RPRX Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 5/18/2017 10:24:46 AM - Followers: 72 - Board type: Free - Posts Today: 0

http://www.reprosrx.com
http://tinyurl.com/yeoe2d
http://www.reprosrx.com/investors_events.php
http://finance.yahoo.com/q/ks?s=RPRX+Key+Statistics

Repros Therapeutics Inc., a development stage biopharmaceutical company, focused on the development of new drugs to treat hormonal and reproductive system disorders. It is developing Androxal, an oral therapy that normalizes testicular function for the treatment of low testosterone due to secondary hypogonadism. The company is also conducting a phase 2 study of the use of Androxal in the treatment of type 2 diabetes in hypogonadal men. In addition, it is developing Proellex, an orally administered selective blocker of the progesterone receptor in women for the treatment of uterine fibroids and endometriosis; and phentolamine-based product candidate VASOMAX for the treatment of male erectile dysfunction. The company was formerly known as Zonagen, Inc. and changed its name to Repros Therapeutics, Inc. in May 2006. Repros Therapeutics, Inc. was founded in 1987 and is based in The Woodlands, Texas.



 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
RPRX
Current Price
Volume:
Bid Ask Day's Range
RPRX News: Current Report Filing (8-k) 05/22/2017 04:07:12 PM
RPRX News: Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) 05/18/2017 04:36:42 PM
RPRX News: Repros Announces Pricing of $3.0 Million Public Offering Of Common Stock And Warrants To Purchase Common Stock 05/18/2017 08:45:00 AM
RPRX News: Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) 05/18/2017 06:05:21 AM
RPRX News: Current Report Filing (8-k) 05/17/2017 05:06:12 PM
PostSubject
#8314   Delisting next. willlbone 05/18/17 10:24:46 AM
#8313   No date or price on offering suggest they hiwatt1959 05/17/17 11:28:30 PM
#8312   dilution coming...stick a fork in this company :( warrior198 05/17/17 08:10:46 PM
#8311   I hope you're correct and something positive happens. Brain Mills 05/11/17 03:34:30 AM
#8310   They should submit liver data this week and hiwatt1959 05/10/17 11:33:55 PM
#8309   What is the plan regarding cash? They Brain Mills 05/10/17 04:46:47 PM
#8308   New corporate presentation. hiwatt1959 05/03/17 03:51:36 PM
#8307   Dead Cat Bounce or does someone know something? damizo 04/26/17 03:07:51 PM
#8306   Nice bounce of those earlier week lows. damizo 04/26/17 02:40:02 PM
#8305   Sinking like a rock on small volume. willlbone 04/24/17 10:47:58 AM
#8304   Below is trial design for Allergan P3 Pearl hiwatt1959 04/23/17 12:08:52 AM
#8303   We claim: hiwatt1959 04/22/17 11:07:43 PM
#8302   Add Bayer to the sprm list that wants hiwatt1959 04/19/17 11:46:32 PM
#8301   The FDA only allowed Allergan to do 2 hiwatt1959 04/18/17 10:03:12 PM
#8300   are you saying allergan could be interested? warrior198 04/17/17 08:41:15 PM
#8299   Note that Ulipristal Acetate is Allergan's SPRM. hiwatt1959 04/17/17 07:03:09 PM
#8298   Wrong poster. Oops. TheSerb 04/13/17 07:50:29 AM
#8297   The Company believes the high concentrations of the hiwatt1959 04/12/17 09:57:50 PM
#8296   what do you mean by hint? warrior198 04/12/17 02:54:00 PM
#8295   Hmm Interested on what's happening here......hint? TheSerb 04/12/17 09:52:43 AM
#8294   The last time Rprx supplied additional data to hiwatt1959 04/10/17 09:20:10 PM
#8293   For Rprx not to pursue the vaginal Proellex hiwatt1959 04/10/17 08:23:33 PM
#8292   What is your opinion of today's Proellex news? damizo 04/10/17 09:57:26 AM
#8291   When you look at the competition for Proellex, hiwatt1959 04/02/17 07:35:26 PM
#8290   The easiest way is to go to hiwatt1959 04/02/17 02:36:42 PM
#8289   Is there a place we can get an warrior198 04/02/17 12:58:44 PM
#8288   Thanks damizo 04/02/17 10:12:45 AM
#8287   By all appearances, Rprx is positioning itself for hiwatt1959 04/01/17 09:34:45 PM
#8286   Scan down to 3.3.4. They are in stop hiwatt1959 04/01/17 08:33:04 PM
#8285   Actually after a closer look i think they warrior198 03/29/17 07:33:03 PM
#8284   Im not an expert on the EU approval warrior198 03/29/17 07:09:27 PM
#8283   Do you have a link for this? damizo 03/28/17 09:45:35 PM
#8282   EU update on Enclomiphene. hiwatt1959 03/23/17 11:11:42 PM
#8281   Full transcript of Dec adcom on secondary hypogonadism hiwatt1959 03/08/17 07:52:16 PM
#8280   Esmya, length of treatment 12 weeks, Proellex 18 weeks. hiwatt1959 02/26/17 09:48:25 PM
#8279   Allergan released final P3 results for Esmya, the hiwatt1959 02/26/17 02:24:32 PM
#8278   Institutional holdings up to 28.2% from a low hiwatt1959 02/16/17 06:43:08 AM
#8277   A new study from Boston University Medical Center hiwatt1959 02/13/17 11:30:59 PM
#8276   New younger CEO announced, Larry Dillaha, age 52, hiwatt1959 02/05/17 08:18:34 PM
#8275   We are primed! guest613 01/03/17 01:32:13 PM
#8274   Thank's for the info.! ?? ?? lecorb 12/06/16 10:35:49 AM
#8273   THAK´S lecorb 12/06/16 10:29:38 AM
#8272   RPRX 3$ Call Options Fills at 3 Cents Stockexpertpro 12/06/16 10:25:58 AM
#8271   $5.50 price target. Shares Rally Following Ladenburg Upgrade lecorb 11/16/16 11:34:14 AM
#8270   Oversold. TheKobra 11/03/16 04:14:46 PM
#8269   In @1.52 today. Ovesold. TheKobra 11/03/16 04:13:55 PM
#8268   I bought in today @ 2.15 lets see dave86 10/05/16 03:12:52 PM
#8267   ANNNNNNNND, WE'RE OFF AND RUNNING!! HandyMan2000 10/05/16 10:40:33 AM
#8266   RPRX bullish 2.17 stocktrademan 09/19/16 12:27:50 PM
#8265   NEWS OUT!!!!!! HandyMan2000 09/12/16 11:47:36 AM
PostSubject